Goldman Sachs’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-131,000
Closed -$1.64M 7092
2014
Q4
$1.64M Sell
131,000
-123,500
-49% -$1.26M ﹤0.01% 4057
2014
Q3
$2.36M Buy
254,500
+104,600
+70% +$802K ﹤0.01% 3775
2014
Q2
$977K Buy
+149,900
New +$991K ﹤0.01% 4709

Other funds holding CCRN

Goldman Sachs's CCRN Position: Q1 2026 in Review

Goldman Sachs increased its Cross Country Healthcare (CCRN) stake by 122% in Q1 2026, buying an estimated $1.82M and bringing the position to 369,820 shares worth $3.48M. The position accounts for ﹤0.01% of the portfolio, ranked #4038.

Goldman Sachs first reported a position in CCRN in Q2 2013 and has held it in 49 quarters since. The position peaked at $17M in Q1 2023. 151 funds tracked by Wall St. Rank hold CCRN as of Q1 2026.

  • Goldman Sachs held 369,820 shares of Cross Country Healthcare worth $3.48M as of Q1 2026.
  • Goldman Sachs bought 203,501 Cross Country Healthcare shares in Q1 2026, an estimated $1.82M.
  • Cross Country Healthcare made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #4038 holding.
  • Goldman Sachs first reported a position in Cross Country Healthcare in Q2 2013 and has held it in 49 quarters since.
  • Goldman Sachs's Cross Country Healthcare position peaked at $17M in Q1 2023.
  • 151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.